NN7535-7807 HIBISCUS 2
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Novo Nordisk, Inc.
Start Date
March 8, 2025
End Date
September 1, 2027
Administered By
Medicine, Hematology
Awarded By
Novo Nordisk, Inc.
Start Date
March 8, 2025
End Date
September 1, 2027